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ABSTRACT 
Beta-thalassemia therapy is developed by increasing γ-globin production which binds to α-globin 
to form haemoglobin fetal (HbF). Meanwhile, DNA methyltransferase 1 (DNMT1) and lysine 
specific demethylase 1 (LSD1) play an important role in silencing the HbF gene by inhibiting the 
production of HbF and inducing haemoglobin subunit alpha (HbA) expression. 6-Shogaol and 
curcumin induce HbF by inhibiting signal transducer and activator of transcription 3 (STAT3) 
expression. Therefore, this study predicts the interaction between 6-shogaol and curcumin on 
DNMT1 and LSD1. The protein structure of DNMT1 (3SWR) and LSD1 (6KGP) was prepared by 
removing the water molecules, while the validation step was performed by separating protein from 
native ligands (sinefungin for 3SWR and flavine-adenine dinucleotide (FAD) for 6KGP) in new 
protein data bank files. Furthermore, the protein was docked with a native ligand to obtain grid 
box coordinates, while the root means standard deviation (RMSD) was calculated from the 
conformation results of the validation process. 6-Shogaol and curcumin were docked with 
coordinates of the validation results, and the best conformation was visualized with Discovery 
Studio. The validation step results in the RMSD value of 0.861Å and 1.410Å for DNMT1 and 
LSD1, respectively. The binding affinity of 6-shogaol and curcumin on DNMT1 was -6.5 kcal/mol 
and -8.0 kcal/mol, respectively. Furthermore, the binding affinity of 6-shogaol and curcumin on 
LSD1 was -8.2 kcal/mol and -10.1 kcal/mol, respectively. Amino acid residues found in DNMT1 
interaction include Gly1147, Phe1145, Glu1168, Asn1278, Pro1225, Leu1151, Val1580, Ala1579, 
Asn1578, Trp1170, and Ala1579; meanwhile, Val288, Ser289, Arg310, Gly285, Thr624, Leu659, 
Lys661, Arg316, Leu625, Tyr761, Trp751, Gly330, and Leu659 were found in LSD1. This study 
showed that curcumin has the potential to inhibit DNMT1 as well as LSD1 proven by lower 
bonding energy and stronger bond types compared to sinefungin and FAD native ligands and 
other DNMT1 and LSD1 inhibitors. 
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INTRODUCTION  
Beta-thalassemia is a hereditary 
disease in which haemoglobin production is 
inhibited, causing anaemia. Haemoglobin is 
not formed due to insufficient production of β-
globin [1]. In general, Indonesia has a high 
thalassemia carrier frequency of 5% [2], 
distributed in West Java, Jakarta, and Central 
Java and Yogyakarta provinces [3]. The 
prevalent treatments for β-thalassemia 
include iron chelation therapy, surgery for 
removing the gallbladder, transplantation of 
bone marrow, and regular blood transfusion. 
The three former methods display several 
drawbacks making the latter the mainstay of 
β-thalassemia treatment. However, this 
treatment also increases the risk of infection 
and causes chills, anaphylaxis, and iron ions 
accumulation in the heart, liver, and 
endocrine glands [1]. 
Beta-thalassemia therapy developed 
by increasing γ-globin quantity which binds to 
α-globin to form haemoglobin fetal (HbF, 
α2γ2) is an alternative for β-thalassemia 
treatment. The α-globin can pair and restore 
normal erythrocyte function, so the disease 
severity could be suppressed [4]. However, 
the HbF production could be inhibited by DNA 
methyltransferase 1 (DNMT1) and lysine-
specific demethylase 1 (LSD1) which play an 
important role in silencing the HbF gene and 
inducing haemoglobin subunit alpha (HbA) 
expression. Thus, inhibition of DNMT1 and 
LSD1 could increase the HbF expression [5]. 
6-Shogaol, discovered in the rhizome 
of Zingiber officinale, has anti-inflammatory, 
antioxidant, and anti-cancer activities. 6-
Shogaol induces apoptosis in cancer cells 
and influences the formation of reactive 
oxygen species. Meanwhile, curcumin, an 
active compound of Curcuma longa, is a 
polyphenol that displays anti-inflammatory, 
anticarcinogenic, antiproliferation, and 
antioxidant properties. Curcumin inhibits 
catalase and superoxide dismutase activity 
while increasing proapoptotic protein activity. 
6-Shogaol and curcumin have also been 
found to increase HbF production by 
inhibiting mRNA signal transducer and 
activator of transcription 3 (STAT3) 
expression in K562 cells [6]. Therefore, this 
study aims to perform in silico molecular 
docking to explore the interaction of 6-




1. Ligands and Proteins Preparation 
Docking study was performed on 
Windows computer Intel® Celeron® CPU 
N3060 @1,60GHz (2CPUs) 4096MB RAM 
using Intel® HD Graphics. Meanwhile, 6-
shogaol and curcumin structures were 
obtained from PubChem 
(https://pubchem.ncbi.nlm.nih.gov/) and were 
optimized with Avogadro 1.2.0 
(http://avogadro.cc/) [7]. The proteins 
DNMT1 (3SWR) and LSD1 (6KGP) were 
retrieved from Protein Data Bank (PDB) 
(https://www.rcsb.org/). Furthermore, ligands 
and proteins were prepared with 
AutoDockTools 1.5.7 through the removal of 
water molecules, the addition of polar 
hydrogen atoms and Gasteiger changes, and 
rotatable bonds. The obtained PDB files were 
converted to partial charge (Q) and atom type 
(T) (PDBQT) format files. 
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2. Validation 
The redocking procedure was 
executed with native ligands of each protein 
(sinefungin for 3SWR and flavine-adenine 
dinucleotide (FAD) for 6KGP) using 
AutoDock Vina [8]. The position of each 
native ligand in the active protein site was 
utilized for grid center and box size parameter 
determination with a spacing of 1 Å. 
Furthermore, the native ligand was flexible, 
while the protein was in a rigid condition. The 
exhaustiveness value was set to eight as 
default [8], and the configuration file was run 
with AutoDock Vina at Command Prompt 
(CMD), while the validation result was 
expressed as RMSD (Root Mean Square 
Deviation) with PyMol 2.4.0.  
3. Molecular Docking 
A similar process of redocking was 
adapted for 6-shogaol and curcumin using 
Autodock Vina. The conformation and 
interactions of docking results were 
visualized using Discovery Studio 2020 
(https://www.3ds.com/). 
 
RESULTS AND DISCUSSION 
1. Ligands and Proteins Preparation 
6-Shogaol and curcumin structure was 
retrieved from PubChem followed by 
optimization using Avogadro 1.2.0. The 
ligands were prepared by the addition of all 
hydrogen atoms, Gasteiger changes, and 
rotatable bonds. The obtained PDB files were 
then converted into PDBQT files and 
prepared for the docking process. 
Furthermore, ligands preparation also 
showed that both 6-shogaol and curcumin 
have 10 torsions, including the best 
conformation with the lowest energy. 
The crystal structure of DNMT1 
(3SWR) and LSD1 (6KGP) proteins at a 
resolution of 2.49Å and 2.25Å was retrieved 
from PDB and used in this study. Both 
proteins have good resolution [9] and native 
ligand, meanwhile, 3SWR (601-1600) and 
6KGP (172-832;901-909) crystallographic 
data indicated that both contain sinefungin 
and FAD native ligand, respectively [10,11]. 
Furthermore, 3SWR and 6KGP were 
prepared via the removal of water molecules 
and native ligands extraction followed by 
optimization of the prepared proteins using 
MMFF94 in Avogadro which is commonly 
applied for organic compounds [12]. 
Sinefungin and FAD co-crystallized ligands 
extraction from the binding site showed that 
the center coordinates and grid box size of 
active sites of 3SWR were x=-5.041, y=-
0.949, z=31.815 and 14 × 18 × 20 Å while for 
3KGP were x=25.776, y=43.519, z=-19.881 
and 22 × 26 × 16 Å. 
2. Validation 
Validation through the redocking 
procedure was performed to ascertain the 
docking process. Sinefungin and FAD 
redocking to the active site in the 3SWR and 
6KGP crystals was successful and indicated 
that the native ligands were docked back onto 
the binding sites. In addition, the acceptability 
of the validation was proven by overlaying the 
docked sinefungin and FAD with similar co-
crystallized structures (Figure 1 and 2). This 
step produced RMSD values of 0.861 Å and 
1.410 Å for 3SWR and 6KGP, respectively. 
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Figure 1. Overlays of redocking ligand (white) 
with reference ligand from 
crystallography (red) at 3SWR 
 
 
Figure 2. Overlays of redocking ligand (white) 
with reference ligand from 
crystallography (red) at 6KGP 
Interaction analysis using Discovery 
Studio 2020 indicated that sinefungin 
interacted with 3SWR through eight hydrogen 
bonding and five hydrophobic interactions, 
while FAD had 26 hydrogen bonds, one 
electrostatic interaction and 20 hydrophobic 
interactions with 6KGP. Sinefungin was 
bound to Val1580, Leu1151, Glu1168, 
Met1169, Phe1145, Gly1149, Gly1150 
residues of 3SWR by hydrogen bonding 
interaction (Figure 3). A similar interaction of 
FAD to 6KGP was formed through Gly28, 
Val288, Ser289, Arg310, Arg316, Arg316, 
Arg316, Met332, Val333, Val590, Thr624, 
Val811, Glu308, Val333, Glu308, Val590, 
Gly285, Gly287, Gly315, Gly800, Val811, 




Figure 3. Visualization of validation results 3SWR with sinefungin in 2D and 3D 
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Figure 4. Visualization of validation results 6KGP with FAD in 2D and 3D 
 
The hydrophobic interactions occurred 
between the docked sinefungin and 3SWR 
via Pro1225, Leu1247, Cys1191, Met1169, 
Phe1145 residues. Meanwhile, for FAD, the 
hydrophobic interactions were formed by 
Ala309, Ala331, Ala331, Trp751, Trp751, 
Trp756, Tyr761, Tyr761, Gly330, Ala331, 
Gly330, Ala331, Leu659, Arg316, Trp751, 
Trp751, Val590, Leu625, Ala309, Leu625, 
Val629, Ala331 residues of 6KGP. 
Furthermore, one electrostatic interaction 
was found between the docked FAD with 
Arg316 residue of 6KPG. These results 
produced a good RMSD value (<2.0 Å) [13], 
while corresponding interactions of the co-
crystallized docked ligands indicated that the 
redocking is appropriate and the protocol is 
applicable for the next docking process. 
3. Molecular Docking 
The docking process was performed 
using Autodock Vina by flexible docking, 
given that the ligands were flexible, and the 
proteins were rigid. The results expressed as 
binding affinity represent the best 
configuration of the ligands in the protein 
binding sites. Meanwhile, the negative value 
of binding energy indicates stronger 
interaction of ligand-protein and better 
prediction [14]. The native ligand, sinefungin 
of 3SWR, had binding energy of -9.0 
kcal/mol, while 6-shogaol and curcumin 
produced interaction with binding energy 
values of -6.5 and -8.0 kcal/mol, respectively. 
A previous study showed that caffeic acid, 
hydroxycinnamic acid and polyphenols 
derivate has an IC50 value of 3.0 μM [15] and 
binding energy of -5.32 kcal/mol [16]. 
Furthermore, genistein inhibited DNMT1 in 
male rats [17] and produced a binding energy 
value of -6.39 kcal/mol [16]. Meanwhile, 
parthenolide, a sesquiterpene lactone of the 
germacranolide class, showed DNMT1 
inhibitory activity with an IC50 value of 3.5 μM 
[18] and binding energy of -6.34 kcal/mol [16].  
The binding energy value of curcumin 
and 6-shogaol indicated the potent activity of 
both compounds as DNMT1 inhibitors. 
Furthermore, the binding mode analysis of 
3SWR as shown in Figures 5 and 6 indicated 
that the interaction of curcumin through 
hydrogen bonding occurred via Asp700, 
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Glu1168, Ala699, and Phe1145 residues 
through hydrogen bonding. Hydrophobic 
interactions of curcumin with 3SWR also 
occurred via Pro1225, Trp1170, Ala1173, 
Asn1578, Ala1579, Val1580 and Leu1151 
residues. Besides, some important amino 
acid residues involved in the interaction of 
curcumin with DNMT1 include Glu1168, 
Phe1145, Pro1225, Trp1170, Asn1578, 
Ala1579 and Val1580 [19]. Meanwhile, 6-
shogaol is bound to Asn1267, Phe1145 and 
Gly1147 residues. It also formed hydrophobic 
interactions with Asn1578, Ala1579, 
Val1580, Leu1151, Ala699, and Pro1225 
residues. This result is in line with Xie et al. 
(2019) which stated that the interaction of 6-
shogaol with DNMT1 (3SWR) occurred 
through Phe1145, Gly1147, Asn1578, 
Ala1759, Val1580, and Pro1225 residues.
 
 
Figure 5. Visualization of docking results 3SWR with curcumin in 2D and 3D 
 
 
Figure 6. Visualization of docking results 3SWR with 6-shogaol in 2D and 3D 
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Figure 7. Visualization of docking results 6KGP with 6-shogaol in 2D and 3D 
 
Figure 8. Visualization of docking results 6KGP with curcumin in 2D and 3D
The binding energy of FAD as a native 
ligand of 6KGP was -16.2 kcal/mol while 6-
shogaol and curcumin were -8.2 and -10.1 
kcal/mol, respectively. Oleacin, a phenolic 
LSD1 inhibitor, showed inhibitory activity with 
an IC50 value of 2.5 μmol/L and binding 
energy of -9.33 kcal/mol [20]. Furthermore, a 
selective LSD1 inhibitor namely iadademstat 
produced binding energy of -9.09 kcal/mol 
[21]. 
The interactions analysis of 6-shogaol 
with 6KGP indicated hydrogen bonding 
through Val288, Ser289, Arg310 and Gly285 
residues (Figure 7). This result correlated 
with the amino acids responsible for inhibitory 
activity namely Val288, Ser289, Gly314, 
Tyr624 and Lys661 [19].  Meanwhile, 
curcumin in 6KGP exhibits hydrogen bonding 
interaction with Thr624, Leu659, and Lys661 
residues (Figure 8). The Thr624 and Lys661 
residues are two important amino acids 
responsible for increasing the inhibitory 
activity. In addition, Leu659 is also a pivotal 
residue for the interaction of diaryene, a 
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stilbene derivative, with LSD1. This 
compound showed an inhibitory activity with 
pIC50 value of 4,991 [19]. DNMT1 and LSD1 
bind to BCL11A, hence, when both proteins 
are inhibited, the mechanism of silencing off 
HbF performed by BCL11A is averted. 
 
CONCLUSION 
Based on this study, curcumin has 
greater interaction to both DNMT1 and LSD1. 
Therefore, inhibition of both proteins by 
curcumin and 6-shogaol compounds may 
increase the production of HbF in the body 
and reduces thalassemia severity and the 
need for blood transfusions. Further study is 
required to examine this potential effect of 
curcumin as a compound for beta-
thalassemia therapy. 
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